Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8168605 Polymeric oligonucleotide prodrugs

Patent 8168605 was granted and assigned to Enzon Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Enzon Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81686050

Patent Inventor Names

Hong Zhao0

Richard B. Greenwald0

Date of Patent

May 1, 2012

Patent Application Number

125447530

Date Filed

August 20, 2009

Patent Citations Received

‌

US Patent 11873490 Antisense oligomers for treatment of conditions and diseases

‌

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

‌

US Patent 11891605 Reducing intron retention

Patent Primary Examiner

‌

Tracy Vivlemore

Patent abstract

Polymer conjugates containing nucleotides and/or oligonucleotides are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8168605 Polymeric oligonucleotide prodrugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API